510(k) K103531
K103531 is an FDA 510(k) premarket notification submitted by Tokyo Boeki Medisys, Inc. for the device "PRESTIGE 24I; BIOLIS 24I; MGC 240". The FDA issued a decision of Substantially Equivalent on Dec 1, 2011. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Tokyo Boeki Medisys, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 1, 2011
- Date Received
- Dec 1, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Tokyo Boeki Medisys, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.